Health Professional Radio - Podcast

Dr. W. Michael Korn, Chief Medical Officer at Caris Life Sciences® and Dr. Philip A. Philip, who serves as the Kathryn Cramer, MD, Endowed Chair in Cancer Research and an investigator on this study discuss the data presentation from the American Society of Clinical Oncology, (ASCO20) Virtual Scientific Program, Abstract 4629/Poster 237: Enrichment of alterations in targetable molecular pathways are enriched in KRAS wild-type (WT) pancreatic cancer (PC).